Entitlement offer Completed
PYC Therapeutics entitlement offer
A$653m raised
Announced 2 Feb 2026 · ASX: PYC · A$1.50 cash per share
Advisers
Lead managers
- Lead manager
- Joint lead manager
- Issuer
- PYC Therapeutics
- Structure
- Accelerated non-renounceable entitlement offer
- Completed
- 4 Mar 2026
- Sector
- Biotech and pharmaceuticals
Similar deals
- Clarity Pharmaceuticals placement Jul 2025 · A$203m · Biotech and pharmaceuticals
- PYC Therapeutics entitlement offer Feb 2025 · A$146m · Biotech and pharmaceuticals
- Botanix Pharmaceuticals placement Feb 2026 · A$40m · Biotech and pharmaceuticals
- Botanix Pharmaceuticals placement Apr 2025 · A$40m · Biotech and pharmaceuticals
- Animalcare Group placement Dec 2024 · A$39m · Biotech and pharmaceuticals
Sources
- 2 Feb 2026 PYC Raising up to $653m to Deliver Human Efficacy Data ASX
- 9 Feb 2026 Retail Offer Booklet ASX
- 4 Mar 2026 Completion of Retail Entitlement Offer ASX